Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Sunday, May 25, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-05-25): -8.11%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-6.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-11.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-6.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-3.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-0.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
1.08%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Lifecore Biomedical, Inc.
Market Cap
$243.48M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-6.64%
3Y Avg
-11.96%
5Y Avg
-6.11%
Market Cap
$242.34M
Return on Invested Capital (ROIC)
-7.08%
TTM Avg
-12.89%
3Y Avg
-21.42%
5Y Avg
-39.95%
Market Cap
$245.38M
Return on Invested Capital (ROIC)
-701.55%
TTM Avg
-3723.51%
3Y Avg
-1911.77%
5Y Avg
-1278.48%
Market Cap
$243.67M
Return on Invested Capital (ROIC)
-1718.59%
TTM Avg
-749.70%
3Y Avg
-566.74%
5Y Avg
-409.31%
Market Cap
$242.30M
Return on Invested Capital (ROIC)
-25.38%
TTM Avg
-99.58%
3Y Avg
-69.59%
5Y Avg
-61.10%
Market Cap
$240.31M
Return on Invested Capital (ROIC)
-69.76%
TTM Avg
-64.00%
3Y Avg
-45.05%
5Y Avg
-31.07%
Market Cap
$248.32M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
Market Cap
$248.50M
Return on Invested Capital (ROIC)
-40.52%
TTM Avg
-35.57%
3Y Avg
-28.84%
5Y Avg
-24.57%
Market Cap
$237.69M
Return on Invested Capital (ROIC)
1.38%
TTM Avg
-1.85%
3Y Avg
-13.83%
5Y Avg
-10.66%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifecore Biomedical, Inc. (LFCR) | $243.48M | N/A | -6.64% | -11.96% | -6.11% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $242.34M | -7.08% | -12.89% | -21.42% | -39.95% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $245.38M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
| Galectin Therapeutics Inc. (GALT)vs › | $243.67M | -1718.59% | -749.70% | -566.74% | -409.31% |
| InflaRx N.V. (IFRX)vs › | $242.30M | -25.38% | -99.58% | -69.59% | -61.10% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.31M | -69.76% | -64.00% | -45.05% | -31.07% |
| Invivyd, Inc. (IVVD)vs › | $248.32M | -59.90% | -142.39% | -118.24% | -103.50% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $248.50M | -40.52% | -35.57% | -28.84% | -24.57% |
| High Tide Inc. (HITI)vs › | $237.69M | 1.38% | -1.85% | -13.83% | -10.66% |
| BioAge Labs Inc. (BIOA)vs › | $237.40M | -28.14% | -28.34% | -154.06% | -154.06% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-05-25 | -8.11% |
| 2025-02-23 | -9.85% |
| 2024-11-24 | -5.56% |
| 2024-08-25 | -5.64% |
| 2024-05-26 | -4.01% |
| 2024-02-25 | -5.82% |
| 2023-11-26 | -8.66% |
| 2023-08-27 | -10.30% |
| 2023-05-28 | -7.63% |
| 2023-02-26 | -27.26% |
| 2022-11-27 | -24.37% |
| 2022-08-28 | -18.70% |
| 2022-05-29 | -19.51% |
| 2022-02-28 | -2.16% |
| 2021-11-30 | 1.48% |
| 2021-08-31 | -0.14% |
| 2021-05-31 | -2.39% |
| 2021-02-28 | -5.78% |
| 2020-11-30 | -10.17% |
| 2020-08-31 | -10.78% |
| 2020-05-31 | -8.27% |
| 2020-02-29 | -4.96% |
| 2019-11-30 | -1.08% |
| 2019-08-31 | 0.03% |
| 2019-05-31 | 0.50% |
| 2019-02-28 | 1.64% |
| 2018-11-30 | 2.83% |
| 2018-08-31 | 2.86% |
| 2018-05-31 | 3.80% |
| 2018-02-28 | 2.30% |
| 2017-11-30 | 1.97% |
| 2017-08-31 | 2.79% |
| 2017-05-31 | 3.51% |
| 2017-02-28 | 4.43% |
| 2016-11-30 | -5.92% |
| 2016-08-31 | -6.12% |
| 2016-05-31 | -6.63% |
| 2016-02-29 | -7.11% |
| 2015-11-30 | 3.62% |
| 2015-08-31 | 3.99% |
| 2015-05-31 | 3.95% |
| 2015-02-28 | 3.72% |
| 2014-11-30 | 4.95% |
| 2014-08-31 | 5.00% |
| 2014-05-31 | 4.81% |
| 2014-02-28 | 4.82% |
| 2013-11-30 | 4.19% |
| 2013-08-31 | 6.69% |
| 2013-05-31 | 7.11% |
| 2013-02-28 | 6.90% |
| 2012-11-30 | 6.20% |
| 2012-08-31 | 4.15% |
| 2012-05-31 | 4.10% |
| 2012-02-29 | 2.43% |
| 2011-11-30 | 2.43% |
| 2011-08-31 | 2.22% |
| 2011-05-31 | 2.46% |
| 2011-02-28 | 4.35% |
| 2010-11-30 | 4.11% |
| 2010-08-31 | 3.76% |
| 2010-05-31 | 3.64% |
| 2010-02-28 | 5.10% |
| 2009-11-30 | 5.00% |
| 2009-08-31 | 4.93% |
| 2009-05-31 | 5.44% |
| 2009-02-28 | 6.59% |
| 2008-11-30 | 8.43% |
| 2008-08-31 | 9.71% |
| 2008-05-31 | 9.92% |
| 2008-02-29 | 11.34% |
| 2007-11-30 | 30.78% |
| 2007-08-31 | 29.35% |
| 2007-05-31 | 23.49% |
| 2007-02-28 | 26.68% |
| 2006-11-30 | 10.94% |
| 2006-08-31 | 9.90% |
| 2006-05-31 | 9.97% |
| 2006-02-28 | 8.49% |
| 2005-11-30 | 7.07% |
| 2005-08-31 | 8.01% |
| 2005-05-31 | 7.48% |
| 2005-02-28 | 7.69% |
| 2004-11-30 | 5.50% |
| 2004-08-31 | 4.70% |
| 2004-05-31 | 4.58% |
| 2003-04-30 | 1.07% |
